Skip to main content
Livermore
Livermore
ZHEN

Viracta Therapeutics, Inc.

VIRXDelisted Jul 10, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001061027

Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in Viracta Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−8 vs. Q4 2022
Shares held
12.2M
−151.6K (−1.2%) vs. Q4 2022
Total value
$19.4M
+$1.37M (+7.6%) vs. Q4 2022
New holders
2
8 more added
Sold out
10
13 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VIRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 48 institutions
Q1 2021: 50 institutionsQ2 2021: 63 institutionsQ3 2021: 68 institutionsQ4 2021: 69 institutionsQ1 2022: 69 institutionsQ2 2022: 63 institutionsQ3 2022: 59 institutionsQ4 2022: 56 institutionsQ1 2023: 48 institutionsQ2 2023: 41 institutionsQ3 2023: 42 institutionsQ4 2023: 42 institutionsQ1 2024: 40 institutionsQ2 2024: 40 institutionsQ3 2024: 38 institutionsQ4 2024: 32 institutionsQ1 2025: 7 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $19.4M
Q1 2021: $92.0MQ2 2021: $151.8MQ3 2021: $124.6MQ4 2021: $51.8MQ1 2022: $62.2MQ2 2022: $44.2MQ3 2022: $52.8MQ4 2022: $18.1MQ1 2023: $19.4MQ2 2023: $14.1MQ3 2023: $10.1MQ4 2023: $5.56MQ1 2024: $9.58MQ2 2024: $4.91MQ3 2024: $1.29MQ4 2024: $583.0KQ1 2025: $3.80KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VIRX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20251$0
Q3 20250$0
Q2 20250$0
Q1 20257$3.80K
Q4 202432$583.0K
Q3 202438$1.29M
Q2 202440$4.91M
Q1 202440$9.58M
Q4 202342$5.56M
Q3 202342$10.1M
Q2 202341$14.1M
Q1 202348$19.4M
Q4 202256$18.1M
Q3 202259$52.8M
Q2 202263$44.2M
Q1 202269$62.2M
Q4 202169$51.8M
Q3 202168$124.6M
Q2 202163$151.8M
Q1 202150$92.0M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Viracta Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding VIRX in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc3,614,662$5.75M0.21%00.0%Unchanged
Citadel Advisors LLC1,557,323$2.48M0.00%+3,644+0.2%Added
Rubric Capital Management LP1,487,385$2.36M0.09%+156,402+11.8%Added
Vanguard Group Inc1,147,912$1.83M0.00%00.0%Unchanged
Laurion Capital Management LP698,000$1.11M0.05%00.0%Unchanged
Samsara BioCapital, LLC689,709$1.10M0.23%00.0%Unchanged
BlackRock Inc.447,801$712.0K0.00%−274−0.1%Reduced
MAI Capital Management379,468$603.4K0.01%−47,448−11.1%Reduced
Adage Capital Partners GP, L.L.C.300,000$477.0K0.00%00.0%Unchanged
Aisling Capital Management LP288,571$458.8K0.22%00.0%Unchanged
Geode Capital Management, LLC224,438$356.9K0.00%00.0%Unchanged
Gilder Gagnon Howe & Co LLC160,515$255.2K0.00%−992−0.6%Reduced
Millennium Management LLC145,347$231.0K0.00%−53,557−26.9%Reduced
Renaissance Technologies LLC125,299$199.0K0.00%−14,488−10.4%Reduced
Bridgeway Capital Management, LLC125,000$198.8K0.01%00.0%Unchanged
Dimensional Fund Advisors LP124,431$197.8K0.00%−55,190−30.7%Reduced
Acadian Asset Management LLC96,135$151.0K0.00%00.0%Unchanged
Jasper Ridge Partners, L.P.92,939$147.8K0.01%00.0%Unchanged
State Street Corp65,867$104.7K0.00%00.0%Unchanged
Ensign Peak Advisors, Inc63,406$100.8K0.00%00.0%Unchanged
Morgan Stanley55,886$88.9K0.00%−6,095−9.8%Reduced
Jane Street Group, LLC55,465$88.2K0.00%+31,264+129.2%Added
Northern Trust Corp38,709$61.5K0.00%+1,389+3.7%Added
Hamilton Lane Advisors LLC35,791$56.9K0.02%00.0%Unchanged
Trust Co of Toledo NA28,000$44.5K0.01%+28,000New
Bank of America Corp23,241$37.0K0.00%+10,422+81.3%Added
Bailard, Inc.19,900$31.6K0.00%+19,900New
Tower Research Capital LLC (TRC)15,599$25.0K0.00%+361+2.4%Added
Two Sigma Advisers, LP15,719$25.0K0.00%−25,300−61.7%Reduced
Two Sigma Investments, LP14,549$23.1K0.00%−45,225−75.7%Reduced
Hoylecohen, LLC14,000$22.3K0.00%00.0%Unchanged
Bank of New York Mellon Corp12,681$20.2K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc12,430$19.8K0.00%00.0%Unchanged
United Bank10,205$16.2K0.00%00.0%Unchanged
Bourgeon Capital Management LLC9,000$14.3K0.00%−8,500−48.6%Reduced
Deutsche Bank AG7,928$12.6K0.00%−7,954−50.1%Reduced
Advisor Group Holdings, Inc.4,564$6.48K0.00%00.0%Unchanged
RP Management, LLC3,700$5.88K0.01%00.0%Unchanged
Royal Bank of Canada3,007$5.00K0.00%+3,000+42,857.1%Added
Barclays PLC2,668$4.24K0.00%−83−3.0%Reduced
JPMorgan Chase & Co721$1.00K0.00%00.0%Unchanged
Wells Fargo & Company335$5330.00%+3+0.9%Added
True Wealth Design, LLC200$3180.00%00.0%Unchanged
Group One Trading, L.P.100$1590.00%−8,327−98.8%Reduced
Baldwin Brothers Inc47$750.00%00.0%Unchanged
Parallel Advisors, LLC8$130.00%00.0%Unchanged
Addison Advisors LLC4$70.00%00.0%Unchanged
ClariVest Asset Management LLC238$00.00%00.0%Unchanged
Blair William & Co0$00.00%−51,843−100.0%Sold out
Veritable, L.P.0$00.00%−24,836−100.0%Sold out
Virtu Financial LLC0$00.00%−19,568−100.0%Sold out
Ergoteles LLC0$00.00%−19,822−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−12,874−100.0%Sold out
UBS Group AG0$00.00%−3,258−100.0%Sold out
Citigroup Inc0$00.00%−98−100.0%Sold out
Money Concepts Capital Corp0$00.00%−14−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−7−100.0%Sold out
Simplex Trading, LLC0$00.00%−237−100.0%Sold out